NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

W hen BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some ...

The move drew sharp criticism from medical and health experts. “Scrapping the fastest platform we have is a reckless move ...

HHS officials are citing an extensive list of studies purported to document harms caused by mRNA vaccines as scientific ...

The government’s cancellation of almost $500 million in contracts involving mRNA vaccines could halt progress on cancer ...

The Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, has launched ...

Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, ...

This week, President Donald Trump called Operation Warp Speed, a public-private federal program that helped speed up the ...

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...